Gupta C, Bentlejewski C A
Department of Pediatric Endocrinology, Children's Hospital of Pittsburgh, Pennsylvania 15213.
Biol Reprod. 1992 Dec;47(6):1151-60. doi: 10.1095/biolreprod47.6.1151.
Recent observations from this laboratory indicated a role of prostaglandin E2 (PGE2) in masculine differentiation of the external genitalia of the fetal mouse, induced by fetal testosterone. In this communication, we further investigated the role played by PGE2 in the testosterone-induced differentiation of the internal genital tract (Wolffian duct) of the fetal mouse. Using in vitro organ culture bioassay of Wolffian duct differentiation, we determined the effect of a PG-depleting agent, namely, anti-PGE2 antibody, and of inhibitors of PG synthesis for their ability to prevent Wolffian duct differentiation in the presence of testosterone. We demonstrated that anti-PGE2 antibody inhibited Wolffian duct differentiation in a dose-dependent manner in embryonic male explants containing fetal testes. At 1:10 dilution, the antibody inhibited the appearance of the entire Wolffian duct as well as growth of the specimen. At 1:100 dilution, however, only development of the Wolffian duct was prevented, as indicated by the absence of regions of the Wolffian duct or by the presence of epithelial disintegration throughout the ductal lumen. The antibody at 1:1000 dilution produced no significant effect on the appearance of the Wolffian duct. PGE2 (10 micrograms/ml) replacement in the medium prevented Wolffian duct disintegration induced by anti-PGE2. We next determined whether the testosterone-dependent Wolffian duct differentiation requires ongoing PG synthesis within the reproductive tract and analyzed the effects of the compounds inhibiting PG synthesis at the level of phospholipase A2 (PLA2) namely, cortisone and dexamethasone-and of those inhibiting at the level of cyclooxygenase-namely, aspirin and indomethacin. We have demonstrated that both PLA2 and cyclooxygenase inhibitors inhibited Wolffian duct differentiation in the male explant, i.e., in the presence of testis. These compounds also prevented the appearance of the Wolffian duct in female explants induced by exogenous testosterone. PGE2 added in the medium blocked the anti-masculinizing effects of PG synthesis inhibitors both in the male and female specimens. Thus, it appears that PG synthesis plays a role in the testosterone-induced masculine differentiation of the Wolffian duct.
该实验室最近的观察结果表明,前列腺素E2(PGE2)在胎儿睾酮诱导的胎鼠外生殖器雄性分化中发挥作用。在本通讯中,我们进一步研究了PGE2在睾酮诱导的胎鼠内生殖道(沃尔夫管)分化中所起的作用。利用沃尔夫管分化的体外器官培养生物测定法,我们确定了一种PG消耗剂(即抗PGE2抗体)以及PG合成抑制剂在睾酮存在下阻止沃尔夫管分化的能力。我们证明,抗PGE2抗体在含有胎儿睾丸的胚胎雄性外植体中以剂量依赖性方式抑制沃尔夫管分化。在1:10稀释时,该抗体抑制了整个沃尔夫管的出现以及标本的生长。然而,在1:100稀释时,仅阻止了沃尔夫管的发育,这表现为沃尔夫管区域的缺失或整个管腔内上皮崩解的存在。1:1000稀释的抗体对沃尔夫管的出现没有显著影响。培养基中添加PGE2(10微克/毫升)可防止抗PGE2诱导的沃尔夫管崩解。接下来,我们确定睾酮依赖性沃尔夫管分化是否需要生殖道内持续的PG合成,并分析了在磷脂酶A2(PLA2)水平抑制PG合成的化合物(即可的松和地塞米松)以及在环氧化酶水平抑制PG合成的化合物(即阿司匹林和吲哚美辛)的作用。我们已经证明,PLA2抑制剂和环氧化酶抑制剂均抑制雄性外植体(即在有睾丸的情况下)中的沃尔夫管分化。这些化合物还阻止了外源性睾酮诱导的雌性外植体中沃尔夫管的出现。培养基中添加的PGE2在雄性和雌性标本中均阻断了PG合成抑制剂的抗雄性化作用。因此,PG合成似乎在睾酮诱导的沃尔夫管雄性分化中发挥作用。